Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection: evolving experience with a 10-sector template
In 2018, urologists in the United States will diagnose over 160,000 men with prostate cancer and will perform transrectal ultrasound-guided biopsies (TRUS-Bx) on many more [1,2]. TRUS-Bx was first popularized by Cooner in 1988 [3]. The technique was further refined by Stamey and colleagues who proposed the systematic sextant biopsy template in 1989 [4]. By the late 1990 ’s, clinicians recognized that a sextant biopsy missed up to 30% of prostate cancers giving rise to the current standard of 10 to 12 core TRUS-Bx [5,6].
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Benjamin T. Ristau, Matthew Allaway, Demetri Cendo, John Hart, Jason Riley, Vasil Parousis, Peter C. Albertsen Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Prostate Cancer | Ultrasound | Urology & Nephrology | USA Health